Investor's Business Daily29d agoneutral
Eli Lilly's Market Cap Balloons Again On This IPO's SetbackEli Lilly shares hit a record high Tuesday after IPO stock Kailera Therapeutics posted lackluster test results for its weight-loss pill.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
532last 24h
2516last 7d
482● bullish (7d)
255● bearish (7d)
197publishers
Investor's Business Daily85d agoneutral
Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In ObesityAnalysts initiated covered Tuesday of IPO stock Kailera Therapeutics, a potential competitor to Lilly and Novo in obesity treatment.